HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroprotective mechanisms of SMTP-7 in cerebral infarction model in mice.

Abstract
Reactive oxygen species (ROS) formation has been found to induce the brain damage following stroke-like events. The aim of the present study was to investigate the effect of Stachybotrys microspora triprenyl phenol-7 (SMTP-7) on the generation of ROS in ischemia-induced cerebral infarction model and in vitro lipid peroxidation. We used immunohistochemistry and real-time reverse-transcription PCR for ex vivo evaluation and thiobarbituric acid-reactive substance reagent assay for in vitro evaluation. We demonstrated that SMTP-7 did not induce enhancement of 4-hydroxynonenal or neutrophil cytosolic factor 2 like t-PA administration at 3 h after ischemia ex vivo and reduce lipid peroxidation in vitro. This compound is the first low molecular weight compound with triplet activities of thrombolytic, anti-inflammatory, and antioxidant activities. We theorized that SMTP-7 is among the pharmacological agents that reduce ROS formation and have been found to limit the extent of brain damage following stroke-like events.
AuthorsKeita Shibata, Terumasa Hashimoto, Koji Nobe, Keiji Hasumi, Kazuo Honda
JournalNaunyn-Schmiedeberg's archives of pharmacology (Naunyn Schmiedebergs Arch Pharmacol) Vol. 384 Issue 1 Pg. 103-8 (Jul 2011) ISSN: 1432-1912 [Electronic] Germany
PMID21533990 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aldehydes
  • Benzopyrans
  • Ferrous Compounds
  • Free Radical Scavengers
  • Neuroprotective Agents
  • Pyrrolidinones
  • Reactive Oxygen Species
  • SMTP 7
  • Thiobarbituric Acid Reactive Substances
  • NADPH Oxidases
  • Ncf2 protein, mouse
  • Tissue Plasminogen Activator
  • 4-hydroxy-2-nonenal
  • Edaravone
  • Antipyrine
Topics
  • Aldehydes (metabolism)
  • Animals
  • Antipyrine (analogs & derivatives, pharmacology)
  • Benzopyrans (pharmacology, therapeutic use)
  • Brain (drug effects, metabolism)
  • Cerebral Infarction (drug therapy, metabolism, prevention & control)
  • Disease Models, Animal
  • Edaravone
  • Ferrous Compounds (pharmacology)
  • Free Radical Scavengers (pharmacology, therapeutic use)
  • Gene Expression (drug effects, genetics)
  • Lipid Peroxidation (drug effects)
  • Male
  • Mice
  • Mice, Inbred Strains
  • NADPH Oxidases (genetics)
  • Neuroprotective Agents (pharmacology, therapeutic use)
  • Pyrrolidinones (pharmacology, therapeutic use)
  • Reactive Oxygen Species (metabolism)
  • Real-Time Polymerase Chain Reaction
  • Thiobarbituric Acid Reactive Substances (metabolism)
  • Tissue Plasminogen Activator (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: